文献速递心血管胸部MRPET

稳定性心绞痛负荷CMR与SPECT远期保障期研究

Long-Term Warranty Period of Stress CMR and SPECT in Stable Angina: Implications for Repeat Testing.
PubMed 文献 · JACC Cardiovasc Imaging · 2026-09-15

CE-MARC试验对752例疑似心绞痛患者进行长期随访,比较负荷CMR与SPECT的远期预后价值。中位随访15.5年,正常负荷CMR结果的保障期为6.8年,SPECT为5.1年。异常CMR是MACE的独立预测因子(HR 2.74)。

要点

  • 正常负荷CMR结果保障期约6.8年,可在6-7年内避免重复检查
  • 异常CMR独立预测MACE,HR达2.74,应积极干预
  • 年龄、吸烟、糖尿病缩短正常结果保障期,需个体化随访

核心结论

  • 异常负荷CMR是稳定性胸痛患者MACE的强独立预测因子(HR 2.74;95% CI 1.70-4.42;P<0.001)
  • 正常负荷CMR结果的保障期为6.8年,正常SPECT结果为5.1年
  • 年龄、吸烟、糖尿病是高危修饰因素,可缩短正常结果的保障期

研究设计与样本

  • 研究类型为CE-MARC试验的前瞻性长期随访研究
  • 入组752例疑似心绞痛患者,652例(86.9%)纳入最终队列
  • 使用侵入性冠状动脉造影作为参考标准
  • 中位随访时间为15.5年(Q1-Q3:12.4-16.6年)

诊断标准与关键数值

  • 正常负荷CMR结果保障期为6.8年,即该时间段内97.5%患者无MACE
  • 正常SPECT结果保障期为5.1年
  • 异常CMR经心血管危险因素校正后HR为2.74(95% CI 1.70-4.42;P<0.001)

临床应用与阅片要点

  • 正常负荷CMR后约6-7年内可适当减少重复功能影像检查频率
  • 异常负荷CMR患者应视为高危人群,建议积极管理和密切随访
  • 对老年、吸烟或糖尿病患者即使负荷影像正常也应缩短复查间隔

局限性

  • 为单中心试验队列的长期随访
  • 随访期间心血管治疗策略可能变化并影响终点事件率

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Few prospective studies have explored the long-term prognostic value and warranty period of functional imaging in patients with stable chest pain. The CE-MARC (Clinical Evaluation of Magnetic Resonance in Coronary Heart Disease) trial recruited 752 patients with suspected angina and demonstrated the high diagnostic accuracy of stress cardiac magnetic resonance (CMR) compared with single-photon emission computed tomography (SPECT), using invasive coronary angiography as the reference standard.

OBJECTIVES: This study aims to assess the comparative long-term prognostic value of stress CMR and SPECT and to establish operational warranty periods for normal test results.

METHODS: Participants in the CE-MARC trial were followed up for major adverse cardiovascular events (MACE), including cardiovascular death, myocardial infarction, and unplanned coronary revascularization. The warranty period identified the time interval during which patients with a normal test result remained 97.5% free of MACE. Multivariable regression analysis identified key warranty period modifiers.

RESULTS: Of 752 recruited patients, 652 (86.9%) with CMR and SPECT with follow-up available formed the study cohort. At a median of 15.5 years (Q1-Q3: 12.4-16.6 years), 40 (6.1%) cardiovascular deaths occurred, 29 (4.4%) patients experienced a myocardial infarction, and 47 (7.2%) unplanned revascularization. After adjustment for cardiovascular risk factors, an abnormal CMR remained a strong independent MACE predictor (HR: 2.74; 95% CI: 1.70-4.42; P < 0.001). Patients with a normal test result had a warranty period of 6.8 years for stress CMR and 5.1 years for SPECT. Age, smoking, and diabetes identified higher-risk patients who had a reduced warranty period for a normal result.

CONCLUSIONS: In a long-term prospective study of patients with stable chest pain, stress CMR remained a strong, independent predictor of hard cardiovascular events, with a warranty period of almost 7 years for a normal scan. (Clinical Evaluation of Magnetic Resonance in Coronary Heart Disease; [CE-MARC]; ISRCTN77246133).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Bisaccia, Swoboda, Younger, et al. Long-Term Warranty Period of Stress CMR and SPECT in Stable Angina: Implications for Repeat Testing. JACC Cardiovasc Imaging. 2026. PMID: 42747370. doi:10.1016/j.jcmg.2026.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。